Top Markets
Coin of the day
20/20 Biolabs Inc. 20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX
Rang in Aktien #33864
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Aktienkurs
$0.5475
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$6.71M
Veränderung (1 Tag)
5.57%
Veränderung (1 Jahr)
-
Land
US
Handel 20/20 Biolabs Inc. (AIDX)

Kategorie

Aktien-Split-Historie für 20/20 Biolabs Inc. (AIDX)
Die Aktie 20/20 Biolabs Inc. (Symbol: AIDX) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 17, 2026 statt.
Eine AIDX-Aktie, die vor dem Aug 17, 2026 gekauft wurde, entspricht heute 0 AIDX-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber